Delgado, A.;                     Griera, R.;                     Llor, N.;                     López-Aguilar, E.;                     Busquets, M.A.;                     Noé, V.;                     Ciudad, C.J.    
        Trioleyl Pyridinium, a Cationic Transfection Agent for the Lipofection of Therapeutic Oligonucleotides into Mammalian Cells. Pharmaceutics 2023, 15, 420.
    https://doi.org/10.3390/pharmaceutics15020420
    AMA Style
    
                                Delgado A,                                 Griera R,                                 Llor N,                                 López-Aguilar E,                                 Busquets MA,                                 Noé V,                                 Ciudad CJ.        
                Trioleyl Pyridinium, a Cationic Transfection Agent for the Lipofection of Therapeutic Oligonucleotides into Mammalian Cells. Pharmaceutics. 2023; 15(2):420.
        https://doi.org/10.3390/pharmaceutics15020420
    
    Chicago/Turabian Style
    
                                Delgado, Ana,                                 Rosa Griera,                                 Núria Llor,                                 Ester López-Aguilar,                                 Maria Antònia Busquets,                                 Véronique Noé,                                 and Carlos J. Ciudad.        
                2023. "Trioleyl Pyridinium, a Cationic Transfection Agent for the Lipofection of Therapeutic Oligonucleotides into Mammalian Cells" Pharmaceutics 15, no. 2: 420.
        https://doi.org/10.3390/pharmaceutics15020420
    
    APA Style
    
                                Delgado, A.,                                 Griera, R.,                                 Llor, N.,                                 López-Aguilar, E.,                                 Busquets, M. A.,                                 Noé, V.,                                 & Ciudad, C. J.        
        
        (2023). Trioleyl Pyridinium, a Cationic Transfection Agent for the Lipofection of Therapeutic Oligonucleotides into Mammalian Cells. Pharmaceutics, 15(2), 420.
        https://doi.org/10.3390/pharmaceutics15020420